These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 18217914

  • 1. De novo membranous nephropathy associated with donor-specific alloantibody.
    El Kossi M, Harmer A, Goodwin J, Wagner B, Shortland J, Angel C, McKane W.
    Clin Transplant; 2008; 22(1):124-7. PubMed ID: 18217914
    [Abstract] [Full Text] [Related]

  • 2. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M, Bosio E, Ancona E, Cozzi E.
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B, Kennel A, Ladrière M, Kessler M, Perrier P.
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A case of living-related renal transplant from the donor with membranous nephropathy.
    Akioka K, Okamoto M, Ushigome H, Nobori S, Suzuki T, Sakai K, Sakamoto S, Urasaki K, Yanagisawa A, Fukatsu A, Yoshimura N.
    Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Membranous glomerulopathy following kidney transplantation. Association with renal vein thrombosis in two of nine cases.
    First MR, Mendoza N, Maryniak RK, Weiss MA.
    Transplantation; 1984 Dec; 38(6):603-7. PubMed ID: 6390820
    [Abstract] [Full Text] [Related]

  • 12. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
    Phelan D, Mohanakumar T, Ramachandran S, Jendrisak MD.
    Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X, Ishida H, Yamaguchi Y, Tanabe K.
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [Abstract] [Full Text] [Related]

  • 15. Concurrence of de novo membranous glomerulonephritis and recurrent IgA nephropathy in a renal allograft.
    Pindur J, Mosheim MB, Giron MA, Guerriero WG, Suki W, Truong L.
    Clin Nephrol; 1994 Oct; 42(4):269-72. PubMed ID: 7834922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Oct; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An attempt to extend the donor criteria for successful living-related kidney transplantation from a donor with membranous nephropathy.
    Akioka K, Okamoto M, Ushigome H, Nobori S, Suzuki T, Sakamoto S, Yoshimura N.
    Transplant Proc; 2009 Oct; 41(1):446-9. PubMed ID: 19249577
    [Abstract] [Full Text] [Related]

  • 20. ["De novo" glomerulonephritis in the transplanted kidney].
    Stefanov G, Beleva B, Simeonov P, Minkova V, Anastasov G.
    Vutr Boles; 1989 Oct; 28(2):85-7. PubMed ID: 2669343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.